Apollon Wealth Management »

Ovid Therapeutics shares owned by Apollon Wealth Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Apollon Wealth Management from 13F filings

Historical chart of Apollon Wealth Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Apollon Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Apollon Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $36k 28k 1.30

More positions owned by Apollon Wealth Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Amazon (AMZN)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Pgim Etf Tr Total Return Bon (PTRB)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hartford Fds Exchange Traded Core Bd Etf (HCRB)

View all positions for Apollon Wealth Management

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Vanguard Group
Affinity Asset Advisors
Acadian Asset Management
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Kennedy Capital Management
Ikarian Capital
Millennium Management
Assenagon Asset Management
Schonfeld Strategic Advisors
Marshall Wace
Wells Fargo & Company

View all funds holding Ovid Therapeutics